Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,535
  • Shares Outstanding, K 15,160
  • Annual Sales, $ 47,530 K
  • Annual Income, $ -3,540 K
  • 60-Month Beta 0.42
  • Price/Sales 1.06
  • Price/Cash Flow 6.41
  • Price/Book 1.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.13 +7.99%
on 07/30/20
3.76 -10.11%
on 07/20/20
+0.14 (+4.32%)
since 07/02/20
3-Month
3.10 +9.03%
on 06/04/20
4.14 -18.36%
on 05/05/20
-0.62 (-15.50%)
since 05/04/20
52-Week
3.10 +9.03%
on 06/04/20
6.24 -45.83%
on 08/05/19
-2.73 (-44.73%)
since 08/02/19

Most Recent Stories

More News
Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results

, /PRNewswire/ -- (NASDAQ: CPIX) announced today that it will release second quarter 2020 financial results and Company update after the market closes on . A conference call and live internet webcast...

CPIX : 3.38 (-0.59%)
Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients

, /PRNewswire/ -- Cumberland Pharmaceuticals Inc. a specialty pharmaceutical company, today announced the results of a Level 1 Trauma Center study recently published in the Journal of Orthopedic Trauma....

CPIX : 3.38 (-0.59%)
All You Need to Know About Cumberland (CPIX) Rating Upgrade to Buy

Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CPIX : 3.38 (-0.59%)
New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis

, /PRNewswire/ -- , a U.S. specialty pharmaceutical company, announces a new publication in , detailing the positive clinical outcomes with Vibativ in treating patients with bacteremia or endocarditis....

CPIX : 3.38 (-0.59%)
Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Miss Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of -50.00% and -11.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CPIX : 3.38 (-0.59%)
Cumberland: 1Q Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Wednesday reported a loss of $1.1 million in its first quarter.

CPIX : 3.38 (-0.59%)
Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update

, /PRNewswire/ -- (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020 financial results....

CPIX : 3.38 (-0.59%)
Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results

, /PRNewswire/ --  announced today that it will release first quarter 2020 financial results and a Company update after the market closes on . A conference call and live Internet webcast will be held...

CPIX : 3.38 (-0.59%)
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast

Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast

CPIX : 3.38 (-0.59%)
MED : 174.42 (+2.05%)
NPTN : 9.95 (+1.22%)
EXPI : 22.83 (+13.92%)
4 Top-Ranked Liquid Stocks to Bet on for Alluring Returns

Here are four top-ranked liquid gems that investors can add to portfolio for remarkable returns.

CPIX : 3.38 (-0.59%)
MED : 174.42 (+2.05%)
NPTN : 9.95 (+1.22%)
EXPI : 22.83 (+13.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CPIX with:

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

2nd Resistance Point 3.49
1st Resistance Point 3.44
Last Price 3.38
1st Support Level 3.33
2nd Support Level 3.27

See More

52-Week High 6.24
Fibonacci 61.8% 5.04
Fibonacci 50% 4.67
Fibonacci 38.2% 4.30
Last Price 3.38
52-Week Low 3.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar